tended to be lower with epirubicin 50 or 80mg than with doxorubicin 50mg (19% vs ≤25%) and BCG (38% vs ≤79%). [2] Systemic absorption of intravesical epirubicin is minimal and systemic adverse ...
Epirubicin (4'-epidoxorubicin) is a sterioisomer of the anthracycline doxorubicin. It can be used as treatment or prophylaxis after transurethral resection (TUR) in patients with superficial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback